DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 81 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $325,000 | -97.5% | 8,865 | -96.9% | 0.01% | -97.4% |
| Q1 2021 | $12,817,000 | -30.9% | 285,846 | -12.1% | 0.46% | -25.0% |
| Q4 2020 | $18,555,000 | +36.7% | 325,126 | +22.9% | 0.62% | +10.2% |
| Q3 2020 | $13,576,000 | +12.7% | 264,631 | +31.2% | 0.56% | +6.5% |
| Q2 2020 | $12,046,000 | +182.6% | 201,714 | +94.9% | 0.52% | +112.6% |
| Q1 2020 | $4,262,000 | +1466.9% | 103,510 | +1192.3% | 0.25% | +1800.0% |
| Q3 2019 | $272,000 | -97.0% | 8,010 | -98.0% | 0.01% | -96.4% |
| Q2 2019 | $8,984,000 | -4.0% | 398,421 | -1.1% | 0.36% | -5.2% |
| Q1 2019 | $9,354,000 | -28.5% | 403,034 | -35.3% | 0.38% | -40.7% |
| Q4 2018 | $13,075,000 | -52.1% | 622,904 | -11.6% | 0.64% | -35.8% |
| Q3 2018 | $27,279,000 | +17.1% | 704,514 | +19.0% | 1.00% | +14.0% |
| Q2 2018 | $23,304,000 | +141.5% | 592,224 | +23.0% | 0.88% | +127.1% |
| Q1 2018 | $9,648,000 | -11.8% | 481,439 | -0.2% | 0.39% | -8.1% |
| Q4 2017 | $10,941,000 | +64.3% | 482,626 | +37.6% | 0.42% | +55.4% |
| Q3 2017 | $6,661,000 | – | 350,740 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,086,723 | $85,910,000 | 25.70% |
| SV Health Investors, LLC | 449,951 | $18,525,000 | 15.54% |
| Redmile Group, LLC | 5,116,263 | $210,637,000 | 5.90% |
| Eversept Partners, LP | 414,081 | $17,047,715 | 4.24% |
| Sunesis Advisors, LLC | 96,299 | $3,965,000 | 3.99% |
| Avoro Capital Advisors LLC | 2,000,000 | $82,340,000 | 2.78% |
| Opaleye Management Inc. | 222,000 | $9,140,000 | 2.42% |
| SECTORAL ASSET MANAGEMENT INC | 204,059 | $8,401,000 | 1.61% |
| Artal Group S.A. | 800,000 | $32,936,000 | 1.39% |
| Atika Capital Management LLC | 141,000 | $5,805,000 | 1.11% |